From the Department of Biochemistry (T.G.M., M.A.H.F., R.M.W.K., M.T.J.v.d.B., F.S., P.E.J.v.d.M., J.M.E.M.C.) and Synapse BV (R.M.W.K.), Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands; School of Physiology and Pharmacology (M.T.J.v.d.B.) and School of Clinical Sciences (J.L.J.), University of Bristol, Bristol, United Kingdom; Neural Circuit Development and Regeneration Research Group, Department of Biology, KU Leuven, Leuven, Belgium (L.D.G., L.M.); Department of Haematology, University of Cambridge, Cambridge, United Kingdom (C.B., C.G.); and National Health Service Blood and Transplant, Cambridge Biomedical Campus, Cambridge, United Kingdom (C.B., C.G.).
Arterioscler Thromb Vasc Biol. 2015 Dec;35(12):2554-61. doi: 10.1161/ATVBAHA.115.306153. Epub 2015 Oct 15.
Platelets are increasingly implicated in processes beyond hemostasis and thrombosis, such as vascular remodeling. Members of the matrix metalloproteinase (MMP) family not only remodel the extracellular matrix but also modulate platelet function. Here, we made a systematic comparison of the roles of MMP family members in acute thrombus formation under flow conditions and assessed platelet-dependent collagenolytic activity over time.
Pharmacological inhibition of MMP-1 or MMP-2 (human) or deficiency in MMP-2 (mouse) suppressed collagen-dependent platelet activation and thrombus formation under flow, whereas MMP-9 inhibition/deficiency stimulated these processes. The absence of MMP-3 was without effect. Interestingly, MMP-14 inhibition led to the formation of larger thrombi, which occurred independently of its capacity to activate MMP-2. Platelet thrombi exerted local collagenolytic activity capable of cleaving immobilized dye-quenched collagen and fibrillar collagen fibers within hours, with loss of the majority of the platelet adhesive properties of collagen as a consequence. This collagenolytic activity was redundantly mediated by platelet-associated MMP-1, MMP-2, MMP-9, and MMP-14 but occurred independently of platelet α-granule release (Nbeal2(-/-) mice). The latter was in line with subcellular localization experiments, which indicated a granular distribution of MMP-1 and MMP-2 in platelets, distinct from α-granules. Whereas MMP-9 protein could not be detected inside platelets, activated platelets did bind plasma-derived MMP-9 to their plasma membrane. Overall, platelet MMP activity was predominantly membrane-associated and influenced by platelet activation status.
Platelet-associated MMP-1, MMP-2, MMP-9, and MMP-14 differentially modulate acute thrombus formation and at later time points limit thrombus formation by exerting collagenolytic activity.
血小板在止血和血栓形成以外的过程中(如血管重塑)的作用越来越受到关注。基质金属蛋白酶(MMP)家族成员不仅重塑细胞外基质,还调节血小板功能。在这里,我们系统比较了 MMP 家族成员在流动条件下急性血栓形成中的作用,并评估了随时间推移血小板依赖性胶原降解活性。
MMP-1 或 MMP-2(人)的药理学抑制(MMP-2(小鼠)缺乏)抑制了胶原依赖性血小板激活和流动条件下的血栓形成,而 MMP-9 抑制/缺乏则刺激了这些过程。MMP-3 的缺失没有影响。有趣的是,MMP-14 的抑制导致形成更大的血栓,这与它激活 MMP-2 的能力无关。血小板血栓具有局部胶原降解活性,能够在数小时内裂解固定的染料淬灭胶原和纤维状胶原纤维,从而导致胶原的大部分血小板黏附特性丧失。这种胶原降解活性是由血小板相关的 MMP-1、MMP-2、MMP-9 和 MMP-14 冗余介导的,但独立于血小板α颗粒释放(Nbeal2(-/-) 小鼠)。后者与亚细胞定位实验一致,该实验表明 MMP-1 和 MMP-2 在血小板中呈颗粒分布,与α颗粒不同。虽然 MMP-9 蛋白不能在血小板内检测到,但活化的血小板确实将血浆衍生的 MMP-9 结合到其质膜上。总的来说,血小板 MMP 活性主要与膜相关,并受血小板激活状态的影响。
血小板相关的 MMP-1、MMP-2、MMP-9 和 MMP-14 差异调节急性血栓形成,并且在稍后的时间点通过发挥胶原降解活性限制血栓形成。